Global average gray and white matter N-acetylaspartate concentration in the human brain

NeuroImage

Volumn 41, Issue 2, 2008, Pages 270-276

  Inglese, Matilde ^a   Rusinek, Henry ^a   George, Ilena C ^a   Babb, James S ^a   Grossman, Robert I ^a   Gonen, Oded ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Absolute quantification; Brain; Gray matter; N acetylaspartate (NAA); Proton magnetic resonance spectroscopy (1H MRS); White matter

Indexed keywords

CELL MARKER; N ACETYLASPARTIC ACID;

ADULT; AMINO ACID BRAIN LEVEL; ARTICLE; CONCENTRATION (PARAMETERS); FEMALE; GRAY MATTER; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NERVE CELL; NEUROLOGIC DISEASE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; WHITE MATTER;

ADULT; ASPARTIC ACID; BRAIN; BRAIN CHEMISTRY; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE;

EID: 44149083293     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2008.02.034     Document Type: Article

References (46)

1. Arnold D.L., de Stefano N., Matthews P.M., and Trapp B.D. N-acetylaspartate: usefulness as an indicator of viable neuronal tissue. Ann. Neurol. 50 (2001) 823 discussion 824-825
2. Baslow M.H. Evidence supporting a role for N-acetyl-l-aspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review. Neurochem. int. 40 (2002) 295-300
3. Baslow M.H. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem. Res, 28 (2003) 941-953
4. Benedetti B., Rigotti D.J., Liu S., Filippi M., Grossman R.I., and Gonen O. Reproducibility of the whole-brain N-acetylaspartate level across institutions, MR scanners, and field strengths. AJNR Am. J. Neuroradiol. 28 (2007) 72-75
5. Chard D.T., McLean M.A., Parker G.J., MacManus D.G., and Miller D.H. Reproducibility of in vivo metabolite quantification with proton magnetic resonance spectroscopic imaging. J. Magn. Reson. Imaging 15 (2002) 219-225
6. Clark K.A., Woods R.P., Rottenberg D.A., Toga A.W., and Mazziotta J.C. Impact of acquisition protocols and processing streams on tissue segmentation of T1 weighted MR images. Neuroimage 29 (2006) 185-202
7. De Santi S., de Leon M.J., Rusinek H., Convit A., Tarshish C.Y., Roche A., Tsui W.H., Kandil E., Boppana M., Daisley K., Wang G.J., Schlyer D., and Fowler J. Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol. Aging 22 (2001) 529-539
8. Doyle T.J., Bedell B.J., and Narayana P.A. Relative concentrations of proton MR visible neurochemicals in gray and white matter in human brain. Magn. Reson. Med. 33 (1995) 755-759
9. Florian C.L., Williams S.R., Bhakoo K.K., and Noble M.D. Regional and developmental variations in metabolite concentration in the rat brain and eye: a study using 1H NMR spectroscopy and high performance liquid chromatography. Neurochem. Res. 21 (1996) 1065-1074
10. Gideon P., Danielsen E.R., Schneider M., and Henriksen O. Short echo time proton spectroscopy of the brain in healthy volunteers using an insert gradient head coil. Magn. Reson. Imaging 13 (1995) 105-109
11. Goelman G., Liu S., Hess D., and Gonen O. Optimizing the efficiency of high-field multivoxel spectroscopic imaging by multiplexing in space and time. Magn. Reson. Med. 56 (2006) 34-40
12. Gonen O., Murdoch J.B., Stoyanova R., and Goelman G. 3D multivoxel proton spectroscopy of human brain using a hybrid of 8th-order Hadamard encoding with 2D chemical shift imaging. Magn. Reson. Med. 39 (1998) 34-40
13. Gonen O., Viswanathan A.K., Catalaa I., Babb J., Udupa J., and Grossman R.I. Total brain N-acetylaspartate concentration in normal, age-grouped females: quantitation with non-echo proton NMR spectroscopy. Magn. Reson. Med. 40 (1998) 684-689
14. Hetherington H.P., Pan J.W., Mason G.F., Adams D., Vaughn M.J., Twieg D.B., and Pohost G.M. Quantitative 1H spectroscopic imaging of human brain at 4.1 T using image segmentation. Magn. Reson. Med. 36 (1996) 21-29
15. Inglese M., Li B.S., Rusinek H., Babb J.S., Grossman R.I., and Gonen O. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis. Magn. Reson. Med. 50 (2003) 190-195
16. Inglese M., Ge Y., Filippi M., Falini A., Grossman R.I., and Gonen O. Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis. Neuroimage 21 (2004) 1825-1829
17. Jansen J.F., Backes W.H., Nicolay K., and Kooi M.E. 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology 240 (2006) 318-332
18. Kingsley P.B., Shah T.C., and Woldenberg R. Identification of diffuse and focal brain lesions by clinical magnetic resonance spectroscopy. NMR Biomed. 19 (2006) 435-462
19. Kreis R., Ernst T., and Ross B.D. Absolute quantitation of water and metabolites in the human Brain. II. Metabolite concentrations. J. Magn. Reson., Ser. B 102 (1993) 9-19
20. Li B.S., Babb J.S., Soher B.J., Maudsley A.A., and Gonen O. Reproducibility of 3D proton spectroscopy in the human brain. Magn. Reson. Med. 47 (2002) 439-446
21. Lim K.O., and Spielman D.M. Estimating NAA in cortical gray matter with applications for measuring changes due to aging. Magn. Reson. Med. 37 (1997) 372-377
22. Lopez-Villegas D., Kimura H., Tunlayadechanont S., and Lenkinski R.E. High spatial resolution MRI and proton MRS of human frontal cortex. NMR Biomed. 9 (1996) 297-304
23. McLean M.A., and Barker G.J. Concentrations and magnetization transfer ratios of metabolites in gray and white matter. Magn. Reson. Med. 56 (2006) 1365-1370
24. Michaelis T., Merboldt K.D., Bruhn H., Hanicke W., and Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 187 (1993) 219-227
25. Mikheev, A., Nevsky, G., Govindan, S., Grossman, R.I., Rusinek, H., in press. Fully automatic segmentation of the brain from T1-weighted MRI using Bridge Burner algorithm. J. Magn. Reson Imag.
26. Moffett J.R., Ross B., Arun P., Madhavarao C.N., and Namboodiri A.M. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog. Neurobiol. 81 (2007) 89-131
27. Moonen C.T.W., Sobering G., van Zijl P.C.M., Gillen J., von Kienlin M., and Bizzi A. Proton spectroscopic imaging of human brain. J. Magn. Reson. 98 (1992) 556-575
28. Narayana P.A., Fotedar L.K., Jackson E.F., Bohan T.P., Butler I.J., and Wolinsky J.S. Regional in vivo proton magnetic resonance spectroscopy of brain. J. Magn. Reson. 83 (1989) 44-52
29. Noworolski S.M., Nelson S.J., Henry R.G., Day M.R., Wald L.L., Star-Lack J., and Vigneron D.B. High spatial resolution 1H-MRSI and segmented MRI of cortical gray matter and subcortical white matter in three regions of the human brain. Magn. Reson. Med. 41 (1999) 21-29
30. Petroff O.A., Spencer D.D., Alger J.R., and Prichard J.W. High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy. Neurology 39 (1989) 1197-1202
31. Pfefferbaum A., Adalsteinsson E., Spielman D., Sullivan E.V., and Lim K.O. In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease. Arch. Gen. Psychiatry 56 (1999) 185-192
32. Pfefferbaum A., Adalsteinsson E., Spielman D., Sullivan E.V., and Lim K.O. In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging. Magn. Reson. Med. 41 (1999) 276-284
33. Rigotti D.J., Inglese M., and Gonen O. Whole-brain N-acetylaspartate as a surrogate marker of neuronal damage in diffuse neurologic disorders. AJNR Am. J. Neuroradiol. 28 (2007) 1843-1849
34. Ross B.D., and Bluml S. Magnetic resonance Spectroscopy of the human brain. Anat. Rec. 265 (2001) 54-84
35. Rusinek H., and Chandra R. Brain tissue volume measurement from magnetic resonance imaging. A phantom study. Invest. Radiol. 28 (1993) 890-895
36. Schuff N., Ezekiel F., Gamst A.C., Amend D.L., Capizzano A.A., Maudsley A.A., and Weiner M.W. Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging. Magn. Reson. Med. 45 (2001) 899-907
37. Schuff N., Meyerhoff D.J., Mueller S., Chao L., Sacrey D.T., Laxer K., and Weiner M.W. N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease. Adv. Exp. Med. Biol. 576 (2006) 241-262 discussion 361-243
38. Simmons M.L., Frondoza C.G., and Coyle J.T. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45 (1991) 37-45
39. Soher B.J., van Zijl P.C., Duyn J.H., and Barker P.B. Quantitative proton MR spectroscopic imaging of the human brain. Magn. Reson. Med. 35 (1996) 356-363
40. Soher B.J., Young K., Govindaraju V., and Maudsley A.A. Automated spectral analysis III: application to in vivo proton MR spectroscopy and spectroscopic imaging. Magn. Reson. Med. 40 (1998) 822-831
41. Stadlbauer A., Moser E., Gruber S., Buslei R., Nimsky C., Fahlbusch R., and Ganslandt O. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas. Neuroimage 23 (2004) 454-461
42. Tallan H.H., Moore S., and Stein W.H. N-acetyl-l-aspartic acid in brain. J. Biol. Chem. 219 (1956) 257-264
43. Tedeschi G., Righini A., Bizzi A., Barnett A.S., and Alger J.R. Cerebral white matter in the centrum semiovale exhibits a larger N-acetyl signal than does gray matter in long echo time 1H-magnetic resonance spectroscopic imaging. Magn. Reson. Med. 33 (1995) 127-133
44. Wang Y., and Li S.J. Differentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy. Magn. Reson. Med. 39 (1998) 28-33
45. Weber-Fahr W., Ende G., Braus D.F., Bachert P., Soher B.J., Henn F.A., and Buchel C. A fully automated method for tissue segmentation and CSF-correction of proton MRSI metabolites corroborates abnormal hippocampal NAA in schizophrenia. Neuroimage 16 (2002) 49-60
46. Zaaraoui W., Fleysher L., Fleysher R., Liu S., Soher B.J., and Gonen O. Human brain-structure resolved T(2) relaxation times of proton metabolites at 3 Tesla. Magn. Reson. Med. 57 (2007) 983-989